...
首页> 外文期刊>Neurology: Official Journal of the American Academy of Neurology >A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy.
【24h】

A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy.

机译:dose-comparison审判的托吡酯单一疗法在最近诊断部分癫痫。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To evaluate topiramate as monotherapy in adults and children with recently diagnosed, localization-related epilepsy, comparing two dosages of topiramate in a multicenter, randomized, double-blind study. METHODS: Adults and children (>/=3 years of age) were eligible if the maximum interval since epilepsy diagnosis was 3 years and patients had one to six partial-onset seizures during a 3-month retrospective baseline. At study entry, patients (N = 252) were untreated or receiving one antiepileptic drug for less than 1 month. After randomization to 50 or 500 mg/d topiramate (25 or 200 mg/d if weight
机译:摘要目的:探讨托吡酯单药治疗与最近诊断成人和儿童,localization-related癫痫,比较两个托吡酯的用量多中心、随机、双盲研究。和孩子(> / = 3岁)都有资格癫痫诊断以来的最大时间间隔3年,患者一到六部分性癫痫发作期间3个月回顾基线。在进入研究,患者未处理组(N = 252)或接收一个抗癫痫药物不足1个月。托吡酯(25或200 mg / d如果重量< / = 50公斤),病人仍在这项研究中,直到4个月在最后一个病人被随机或直到病人遇到seizure-related退出标准(例如,有两个癫痫)。的单变量分析time-to-exit,是时候第二次发作病人的96%。结果:time-to-exit(中位数,422天vs293天)喜欢托吡酯的高剂量,但这前后不显著。分析了time-to-exit与time-to-first-seizure作为协变量,不同剂量组之间是显著的(p = 0.01),反映出更高的控制发作率(54%比39%,p = 0.02)和更长的时间time-to-first-seizure vs 108(平均317天天;mg / d托吡酯。与增加time-to-first发作有关(p < 0.01)。感觉异常、体重减轻、腹泻、和感觉迟钝。功效分析是负数,time-to-exit分析,包括time-to-first-seizure作为协变量,群体间的差异控制发作率、寿命更长time-to-first-seizure较高的血清提供的证据表明,托吡酯浓度有效的患者作为单一疗法localization-related癫痫。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号